George J. Bosl, MD | Authors

The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach

July 15, 2016

In this paper, we review the use of serum tumor markers in risk assignment and response evaluation; the treatment of previously untreated and relapsing patients; the role of surgical resection of residual disease, including retroperitoneal node dissection; and the importance of clinical trials for addressing unanswered questions and testing new therapies.

Testicular Granulosa Cell Tumors: Rare Tumors Need to Be Studied Too

August 18, 2009

Granulosa cell tumors of the testis are very rare neoplasms. While most appear to have a benign course, they occasionally metastasize.

Combined-Modality Therapy for Bladder Cancer

September 01, 1997

Radical cystectomy remains standard management for patients with locally advanced T2 through T4, N0, M0 transitional cell carcinoma of the urinary bladder.